Latest action: Ordered to be Reported in the Nature of a Substitute by Voice Vote.
Committee has approved the bill (usually with amendments) and sent it back to the full chamber.
The committee voted to send the bill to the floor of the full chamber. The Speaker of the House schedules a floor vote.
Next: Passed One Chamber
The other chamber (Senate or House) repeats the committee + floor-vote process
Expands pharmacist services and access to healthcare through community pharmacy programs.
The problem
Many Americans have limited access to pharmacy services outside traditional hospital settings. Communities need more healthcare options close to home.
The proposal
The bill allows pharmacists to provide additional clinical services and expands community pharmacy programs. It may increase pharmacist roles in patient care and health services.
The impact
Patients, pharmacists, and healthcare systems are affected. Patients may access more services locally. Pharmacists gain expanded roles. Healthcare costs and delivery may change.
Patients can receive more services at local pharmacies without going to hospitals or doctor offices. This makes healthcare more convenient for people in rural and underserved areas.
Pharmacists can take on expanded roles and responsibilities. This creates new career opportunities and uses their training more fully.
Pharmacists handling certain tasks reduces the workload on busy doctors and clinics. This helps the healthcare system run more efficiently.
Pharmacy services are often cheaper than hospital or doctor office visits. More people using pharmacies could reduce overall healthcare spending.
Expanding pharmacist roles without clear standards could cause inconsistent care quality. Patient safety depends on proper training and oversight of new services.
Insurance companies may not cover new pharmacy services, leaving patients to pay out of pocket. This could limit actual access gains.
Doctors may oppose pharmacists taking on clinical roles they traditionally handled. This professional conflict could slow implementation.
States have different pharmacy laws and regulations. A federal bill might create confusion about what pharmacists can do in each state.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.